TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35023349

Group type: EXPERIMENTAL
Intervention: Active low-level transcutaneous vagus nerve stimulation (tragus), 20 Hz, 1 mA below discomfort threshold, for 1 hour daily for 3 months.
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sham low-level transcutaneous vagus nerve stimulation (earlobe), 20 Hz, 1 mA below discomfort threshold, for 1 hour daily for 3 months.
Number of subjects: 52
Study: 32080686

Group type: EXPERIMENTAL
Intervention: DentalVibe
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional injection (control)
Number of subjects: 60
Study: 35505544

Group type: EXPERIMENTAL
Intervention: Case-control study design
Number of subjects: 0
Study: 616880400

Group type: EXPERIMENTAL
Intervention: ABP-700 (0.25 mg/kg and 0.35 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ABP-700 (1.00 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ABP-700
Number of subjects: 60
Study: 35089982

Group type: EXPERIMENTAL
Intervention: Blue-blocking glasses
Number of subjects: 60

Group type: COMPARATOR
Intervention: Partial blue-blocking glasses
Number of subjects: 60
Study: 32356207

Group type: EXPERIMENTAL
Intervention: Daily preventive zinc dispersible tablet (7 mg/d; PZ)
Number of subjects: 3407

Group type: EXPERIMENTAL
Intervention: Daily micronutrient powder (10 mg zinc/d; MNP)
Number of subjects: 3407

Group type: COMPARATOR
Intervention: Therapeutic zinc supplements for diarrhea treatment (20 mg/d for 10 days; TZ)
Number of subjects: 3407

Group type: COMPARATOR
Intervention: Daily placebo powder (Control)
Number of subjects: 3407
Study: 36293916

Group type: EXPERIMENTAL
Intervention: Static stretching condition (SSC)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control condition (CC, no warm-up)
Number of subjects: 44
Study: 34541920

Group type: EXPERIMENTAL
Intervention: Andexanet alfa
Number of subjects: 32

Group type: COMPARATOR
Intervention: 4-Factor Prothrombin Complex (4F-PCC)
Number of subjects: 32
Study: 33988943

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 100
Study: 32487035

Group type: EXPERIMENTAL
Intervention: Ipilimumab in combination with nivolumab and trastuzumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FOLFOX in combination with nivolumab and trastuzumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ipilimumab or FOLFOX with nivolumab and trastuzumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood-based signatures (e.g. immune response or suppression of anti-HER2 resistance)
Number of subjects: 0
Study: 35129875

Group type: EXPERIMENTAL
Intervention: Alexandrite 755-nm picosecond laser
Number of subjects: 30

Group type: COMPARATOR
Intervention: KTP 532-nm picosecond laser
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both lasers
Number of subjects: 30
Study: 34215339

Group type: EXPERIMENTAL
Intervention: FEIBA
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 36506251

Group type: EXPERIMENTAL
Intervention: Off-clamp LPN
Number of subjects: 249

Group type: COMPARATOR
Intervention: On-clamp LPN
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: RENAL score increase
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Tumor size increase
Number of subjects: 249
Study: 33370174

Group type: EXPERIMENTAL
Intervention: STEP‐KOA
Number of subjects: 345

Group type: COMPARATOR
Intervention: Arthritis Education (AE)
Number of subjects: 345
Study: 34798841

Group type: EXPERIMENTAL
Intervention: Colgate Optic White (GO) toothpaste
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Colgate Total Whitening (GT) toothpaste
Number of subjects: 45

Group type: COMPARATOR
Intervention: Distilled water (GC)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Bencer (GB) toothpaste
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Perfect White Black (GP) toothpaste
Number of subjects: 45
Study: 35420662

Group type: EXPERIMENTAL
Intervention: Bariatric surgery (laparoscopic adjustable gastric banding)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 82
Study: 34461844

Group type: EXPERIMENTAL
Intervention: Postnatal care service utilization
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Mother's and partner's secondary education level and above
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Partner's occupation in civil service and business
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Household income of at least MK50,000
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Joint decision making
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Knowledge of the available PNC services
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Knowledge of at least one postpartum danger sign
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Health facility delivery of last pregnancy
Number of subjects: 600
Study: 32295491

Group type: EXPERIMENTAL
Intervention: Intraosseous application of autologous mesenchymal stromal cells (MSCs) after core decompression (CD)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Core decompression (CD) only
Number of subjects: 21
Study: 35549736

Group type: EXPERIMENTAL
Intervention: TTM-based mobile health application program
Number of subjects: 122
Study: 32470434

Group type: EXPERIMENTAL
Intervention: Autologous haematopoietic stem‐cell transplantation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bortezomib–melphalan–prednisone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bortezomib–lenalidomide–dexamethasone consolidation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lenalidomide maintenance
Number of subjects: 0
Study: 36326863

Group type: EXPERIMENTAL
Intervention: MODSUG diet (50% carbohydrate [20% sugars], 15% protein, 35% fat)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: LOWSUG diet (50% carbohydrate [< 5% sugars], 15% protein, 35% fat)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: LOWCHO diet (8% carbohydrate [< 5% sugars], 15% protein, 77% fat)
Number of subjects: 25
Study: 33593836

Group type: EXPERIMENTAL
Intervention: Cefepime
Number of subjects: 7668

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 7668

Group type: COMPARATOR
Intervention: In-house mortality, colonization with resistant organisms, Clostridiodes difficile infection
Number of subjects: 7668

Group type: EXPERIMENTAL
Intervention: Anti-pseudomonal antibiotics
Number of subjects: 7668
Study: 32276603

Group type: EXPERIMENTAL
Intervention: SEIQoL-DW
Number of subjects: 99

Group type: COMPARATOR
Intervention: SEIQoL-PF/G
Number of subjects: 99
Study: 36058429

Group type: EXPERIMENTAL
Intervention: Belimumab 10mg/kg plus standard therapy (oral glucocorticoids and either cyclophosphamide or mycophenolate mofetil)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo plus standard therapy (oral glucocorticoids and either cyclophosphamide or mycophenolate mofetil)
Number of subjects: 142
Study: 32918332

Group type: EXPERIMENTAL
Intervention: Connective Tissue Grafting (CTG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No Connective Tissue Grafting (Control)
Number of subjects: 60
Study: 32013175

Group type: EXPERIMENTAL
Intervention: Liquid petroleum gas (LPG) cooking distributed to households for 3 months (3 cylinders)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual cooking methods (control group)
Number of subjects: 0
Study: 36219446

Group type: EXPERIMENTAL
Intervention: Audiovisual material (4-minute video)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Paper-based material
Number of subjects: 290
Study: 32914917

Group type: EXPERIMENTAL
Intervention: Technology for falls prevention
Number of subjects: 0
Study: 35996218

Group type: EXPERIMENTAL
Intervention: Culturally and linguistically appropriate self-management program for hearing loss
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Focus group discussions
Number of subjects: 31
Study: 33793282

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) - Change Talk (CT)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Health Education (HE) - Learning Talk (LT)
Number of subjects: 202
Study: 34984808

Group type: EXPERIMENTAL
Intervention: Dulaglutide
Number of subjects: 9543

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9543
Study: 34110925

Group type: EXPERIMENTAL
Intervention: Involved field radiation therapy (IFRT)
Number of subjects: 549

Group type: COMPARATOR
Intervention: Posterior fossa radiation therapy (PFRT)
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Low-dose craniospinal irradiation (LDCSI; 18 Gy)
Number of subjects: 549

Group type: COMPARATOR
Intervention: Standard-dose craniospinal irradiation (SDCSI; 23.4 Gy)
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Involved field radiation therapy (IFRT) in Sonic Hedgehog MB patients
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Low-dose craniospinal irradiation (LDCSI) in group 4 MB patients
Number of subjects: 549
Study: 32541174

Group type: EXPERIMENTAL
Intervention: Nanoliposomal irinotecan plus fluorouracil and folinic acid (nal-IRI + FF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluorouracil and folinic acid (FF) alone
Number of subjects: 0
Study: 36191176

Group type: EXPERIMENTAL
Intervention: Mobile mental health apps (4 different apps used for 4 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control app (most usable)
Number of subjects: 0
Study: 35585696

Group type: EXPERIMENTAL
Intervention: Baloxavir marboxil (high exposure: AUC0-inf 5.13-16.65 μg.hr/mL)
Number of subjects: 1781

Group type: EXPERIMENTAL
Intervention: Baloxavir marboxil (low exposure: AUC0-inf 0.72-5.13 μg.hr/mL)
Number of subjects: 1781
Study: 32275771

Group type: EXPERIMENTAL
Intervention: Rifampicin 10 mg/day (weak induction)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Rifampicin 600 mg/day (strong induction)
Number of subjects: 12
Study: 35839116

Group type: EXPERIMENTAL
Intervention: HFMEA-based predictive care combined with multimodal analgesia
Number of subjects: 150

Group type: COMPARATOR
Intervention: Routine nursing combined with multimodal analgesia
Number of subjects: 150
Study: 34615781

Group type: EXPERIMENTAL
Intervention: Fixed orthodontic appliance
Number of subjects: 110

Group type: COMPARATOR
Intervention: Clear aligners
Number of subjects: 110
Study: 32213783

Group type: EXPERIMENTAL
Intervention: VL25 (25% velocity loss)
Number of subjects: 29

Group type: COMPARATOR
Intervention: VL50 (50% velocity loss)
Number of subjects: 29
Study: 34862162

Group type: EXPERIMENTAL
Intervention: Training session on six communication strategies
Number of subjects: 130

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 130
Study: 32604939

Group type: EXPERIMENTAL
Intervention: Manual therapy sessions based on connective tissue massage
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo group (ultrasound sessions without conductive gel and machine turned off)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 24
Study: 35089910

Group type: EXPERIMENTAL
Intervention: PTSD severity
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Depressive symptoms severity
Number of subjects: 184
Study: 33558661

Group type: EXPERIMENTAL
Intervention: Twice weekly supervised impact loading and resistance exercise (ImpRes)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Supervised aerobic and resistance exercise (AerRes)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Usual care/delayed supervised aerobic exercise (DelAer)
Number of subjects: 135
Study: 34129271

Group type: EXPERIMENTAL
Intervention: Twice a week range of motion (ROM) exercise over a 4 weeks period
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 48
Study: 33499197

Group type: EXPERIMENTAL
Intervention: Inhaling kuromoji tea aroma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drinking kuromoji tea
Number of subjects: 0
Study: 36400737

Group type: EXPERIMENTAL
Intervention: Caring Connections (CC) intervention, a peer-based, recurrent letter writing programme designed to provide moments of positivity.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention control group receiving informational materials on life domains important to a good quality of life.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caring Connections (CC) intervention
Number of subjects: 0
Study: 35743631

Group type: EXPERIMENTAL
Intervention: Integrated Cognitive Rehabilitation Program (ICRP) for 10 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 40
Study: 33243182

Group type: EXPERIMENTAL
Intervention: 12-week customised vestibular rehabilitation (VR) programme consisting of 12 face-to-face sessions and a home exercise programme.
Number of subjects: 100

Group type: COMPARATOR
Intervention: 12-week generic booklet-based home programme with telephone support.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Customised VR intervention.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Generic booklet-based intervention.
Number of subjects: 100
Study: 34311382

Group type: EXPERIMENTAL
Intervention: Cued stop-signal task with varying stop-signal probabilities (0%, 25%, 66%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cued stop-signal task
Number of subjects: 0
Study: 32154734

Group type: EXPERIMENTAL
Intervention: Antepartum educational leaflet
Number of subjects: 3534

Group type: COMPARATOR
Intervention: Control group (no leaflet)
Number of subjects: 3534
Study: 34557931

Group type: EXPERIMENTAL
Intervention: Ranger Drug‐Coated Balloon (DCB)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standard percutaneous transluminal angioplasty (PTA)
Number of subjects: 102
Study: 33731199

Group type: EXPERIMENTAL
Intervention: Kanglaite injections (KLTi) 200 ml per day for 14 days
Number of subjects: 334

Group type: COMPARATOR
Intervention: First-line platinum-based double chemotherapy regimens
Number of subjects: 334
Study: 35942041

Group type: EXPERIMENTAL
Intervention: JET + PCB
Number of subjects: 47

Group type: COMPARATOR
Intervention: PTA + PCB
Number of subjects: 47
Study: 33518358

Group type: EXPERIMENTAL
Intervention: 12-week exercise intervention (Quit and Fit)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (smoking cessation counseling and nicotine lozenges)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Intent-to-treat analysis for intervention group
Number of subjects: 38

Group type: COMPARATOR
Intervention: Intent-to-treat analysis for control group
Number of subjects: 38
Study: 34995105

Group type: EXPERIMENTAL
Intervention: Palbociclib with adjuvant endocrine therapy (ET) for 2 years
Number of subjects: 5743

Group type: COMPARATOR
Intervention: Adjuvant endocrine therapy (ET) alone
Number of subjects: 5743
Study: 34717099

Group type: EXPERIMENTAL
Intervention: Three-dimensional (3D) visualisation intervention (n = 20)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Traditional education control group (n = 18)
Number of subjects: 38
Study: 32647965

Group type: EXPERIMENTAL
Intervention: B85E15
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: B100
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: B85G15
Number of subjects: 5

Group type: COMPARATOR
Intervention: B85G15 and B100
Number of subjects: 5
Study: 36308260

Group type: EXPERIMENTAL
Intervention: Nutritive pacifiers (NPs)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Non-nutritive pacifiers (NNPs)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 33065273

Group type: EXPERIMENTAL
Intervention: Spinal manipulation and electrical dry needling
Number of subjects: 142

Group type: COMPARATOR
Intervention: Spinal mobilization and exercise
Number of subjects: 142
Study: 34098201

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) phone counseling calls
Number of subjects: 382

Group type: COMPARATOR
Intervention: Prenatal and postpartum care as usual (Control)
Number of subjects: 382
Study: 34114720

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 4822

Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 4822
Study: 35427470

Group type: EXPERIMENTAL
Intervention: Digital breast tomosynthesis plus synthesised 2D mammography
Number of subjects: 99869

Group type: COMPARATOR
Intervention: Digital mammography
Number of subjects: 99869
Study: 32216724

Group type: EXPERIMENTAL
Intervention: Bulk-fill flowable resin composites
Number of subjects: 11

Group type: COMPARATOR
Intervention: Conventional flowable resin composites
Number of subjects: 11
Study: 33676840

Group type: EXPERIMENTAL
Intervention: Mel4 antimicrobial peptide‐coated contact lenses (MACL)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Uncoated control lenses
Number of subjects: 176
Study: 34680134

Group type: EXPERIMENTAL
Intervention: Molecular iodine (I2) supplementation (5 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with molecular iodine (Cht+I2)
Number of subjects: 0
Study: 35277146

Group type: COMPARATOR
Intervention: Standardized training module
Number of subjects: 120

Group type: COMPARATOR
Intervention: Hygiene kit
Number of subjects: 120

Group type: COMPARATOR
Intervention: Training module and hygiene kit
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 32783051

Group type: EXPERIMENTAL
Intervention: Paroxysmal AF (PxAF)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: 99-100% AF burden
Number of subjects: 212
Study: 34954044

Group type: EXPERIMENTAL
Intervention: Tucatinib combination (tucatinib + trastuzumab + capecitabine)
Number of subjects: 612

Group type: COMPARATOR
Intervention: Placebo combination (placebo + trastuzumab + capecitabine)
Number of subjects: 612
Study: 34780528

Group type: EXPERIMENTAL
Intervention: Body Project (BP) intervention
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Healthy Weight Program (HW) intervention
Number of subjects: 90

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 90
Study: 33205906

Group type: EXPERIMENTAL
Intervention: Etanercept monotherapy
Number of subjects: 253

Group type: COMPARATOR
Intervention: Methotrexate monotherapy
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Combination therapy (methotrexate plus etanercept)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Rescue therapy (combination regimen)
Number of subjects: 253
Study: 32019823

Group type: EXPERIMENTAL
Intervention: Hand hygiene interventions
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Thematic synthesis of hand hygiene interventions
Number of subjects: 21
Study: 34913147

Group type: EXPERIMENTAL
Intervention: Interactive Dynamic Scalp Acupuncture (IDSA)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Simple Combination Therapy (SCT)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Traditional Scalp Acupuncture (TSA)
Number of subjects: 231
Study: 32241205

Group type: EXPERIMENTAL
Intervention: Enriched cosmetic product (ECP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo cosmetic product (PCP)
Number of subjects: 40
Study: 35099437

Group type: EXPERIMENTAL
Intervention: Simulation-based team training in a simulated environment
Number of subjects: 32

Group type: COMPARATOR
Intervention: Traditional lectures and hands-on pelvic models
Number of subjects: 32
Study: 35285902

Group type: EXPERIMENTAL
Intervention: Test-positive group (TPG)
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Test-negative group (TNG)
Number of subjects: 1032

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 1032
Study: 33992169

Group type: EXPERIMENTAL
Intervention: Threshold compliance tool
Number of subjects: 54
Study: 33325186

Group type: EXPERIMENTAL
Intervention: 1Hr2Dx method for processing and diagnosing prostate biopsies
Number of subjects: 44

Group type: COMPARATOR
Intervention: Routine, slide-based 2D histology
Number of subjects: 44
Study: 34550375

Group type: EXPERIMENTAL
Intervention: Small-for-gestational age (SGA; <10th percentile)
Number of subjects: 735

Group type: EXPERIMENTAL
Intervention: Low birth weight (LBW; <2500 g)
Number of subjects: 735

Group type: EXPERIMENTAL
Intervention: Preterm birth (<37 weeks of gestation)
Number of subjects: 735
Study: 33884713

Group type: EXPERIMENTAL
Intervention: Extra virgin olive oil (EVOO), 25 mL/day for 52 days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sunflower oil, 25 mL/day for 52 days
Number of subjects: 62
Study: 32464532

Group type: EXPERIMENTAL
Intervention: GC-rs4588-A minor allele
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: VDR-rs7975232-A
Number of subjects: 239

Group type: COMPARATOR
Intervention: Control group (healthy Malaysian children)
Number of subjects: 239
Study: 34767896

Group type: EXPERIMENTAL
Intervention: PIZ > median (>14 ml)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: PIZ volume in patients with MACE
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Addition of PIZ to CMR risk model
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Thrombolysis In Myocardial Infarction (TIMI) risk score
Number of subjects: 704
Study: 34736452

Group type: EXPERIMENTAL
Intervention: Integrated Mothers and Babies Course & Early Childhood Development (iMBC/ECD)
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Increase in social support
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Improvement in couple communication
Number of subjects: 374
Study: 32057574

Group type: EXPERIMENTAL
Intervention: Standard Dose (SD) - 2 standard doses on weeks 0 and 4
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Double Dose (DD) - 2 double-standard doses on weeks 0 and 4
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Booster Dose (BD) - 3 standard doses on weeks 0, 4, and 12
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (SD and DD)
Number of subjects: 87
Study: 34767030

Group type: EXPERIMENTAL
Intervention: Bone marrow aspirate concentrate (BMAC) injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) injection
Number of subjects: 60
Study: 33358336

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 μg kg−1 h−1) with propofol infusion
Number of subjects: 349

Group type: COMPARATOR
Intervention: Placebo (saline 0.9%) with propofol infusion
Number of subjects: 349
Study: 35688582

Group type: EXPERIMENTAL
Intervention: Nissen-Sleeve procedure
Number of subjects: 88

Group type: COMPARATOR
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 88